| plasma membrane fusion |
| transmembrane receptor protein tyrosine kinase activity |
| vasculogenesis |
| negative regulation of angiogenesis |
| negative regulation of blood vessel morphogenesis |
| response to retinoic acid |
| negative regulation of vasculature development |
| mesoderm development |
| membrane fusion |
| peptidyl-tyrosine phosphorylation |
| peptidyl-tyrosine modification |
| positive regulation of angiogenesis |
| positive regulation of vasculature development |
| receptor complex |
| negative regulation of cell migration |
| negative regulation of cell motility |
| regulation of angiogenesis |
| negative regulation of cellular component movement |
| angiogenesis |
| regulation of vasculature development |
| negative regulation of locomotion |
| response to acid chemical |
| in utero embryonic development |
| blood vessel morphogenesis |
| blood vessel development |
| vasculature development |
| transmembrane receptor protein tyrosine kinase signaling pathway |
| cardiovascular system development |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| tube morphogenesis |
| enzyme linked receptor protein signaling pathway |
| tube development |
| regulation of cell migration |
| response to lipid |
| membrane organization |
| circulatory system development |
| peptidyl-amino acid modification |
| anatomical structure formation involved in morphogenesis |
| regulation of cell motility |
| negative regulation of developmental process |
| protein phosphorylation |
| embryo development |
| regulation of locomotion |
| regulation of cellular component movement |
| regulation of anatomical structure morphogenesis |
| negative regulation of multicellular organismal process |
| phosphorylation |
| positive regulation of developmental process |
| integral component of plasma membrane |
| ATP binding |
| response to oxygen-containing compound |
| positive regulation of multicellular organismal process |
| tissue development |